Management of Anxiety and Depression in Graves' Disease

Patient Assessment and Risk Stratification

• The American Association of Clinical Endocrinologists recommends assessing for suicidal ideation immediately in patients with Graves' disease, as severe depression can provoke suicide attempts 1, 2
• Patients with a history of depression or anxiety before Graves' diagnosis are at higher risk of persistent psychiatric symptoms, according to the Clinical and Molecular Hepatology guidelines 1, 2
• The presence of suicidal ideation indicates high risk, and patients should be referred to psychiatry or the emergency department immediately 1, 2

Laboratory Tests and Monitoring

• The American Thyroid Association recommends ordering TSH, free T4, and free T3 tests to assess current thyroid status, with a frequency of every 2-4 weeks in the first month 2, 3
• The Endocrine Society suggests monitoring thyroid function tests every 2-3 months after achieving euthyroidism 2, 3

Treatment and Management

• The Cardiovascular Research journal recommends initiating SSRI therapy if depression persists after 2-3 months of stable euthyroidism, as SSRIs are safest in thyroid disease 5, 1, 2
• Cognitive behavioral therapy should be considered for residual anxiety and depression, according to the Nature Reviews Neurology guidelines 5, 6

Psychiatric Symptom Management

• The Clinical and Molecular Hepatology journal advises against initiating antidepressants immediately in patients with hyperthyroidism, as most psychiatric symptoms will improve with thyroid normalization 1, 2
• The Praxis Medical Insights guidelines recommend monitoring psychiatric symptoms weekly during the initial treatment phase, and monthly for the first 6 months after achieving euthyroidism 3